APA (7th ed.) Citation

Tae Hyun Ban, Sua Lee, Hyung Duk Kim, Eun Jeong Ko, Bo-Mi Kim, Kyoung-Woon Kim, . . . Chul Woo Yang. (2021). Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin. Hindawi Limited.

Chicago Style (17th ed.) Citation

Tae Hyun Ban, Sua Lee, Hyung Duk Kim, Eun Jeong Ko, Bo-Mi Kim, Kyoung-Woon Kim, Byung Ha Chung, and Chul Woo Yang. Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin. Hindawi Limited, 2021.

MLA (9th ed.) Citation

Tae Hyun Ban, et al. Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin. Hindawi Limited, 2021.